Aurobindo Pharma USA Inc. 2024-05-15 Health serious FDA
Health · FDA · Recall #FDA-D-0492-2024
Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC… Recall
Issued May 15, 2024 · Aurobindo Pharma USA Inc.
In May 2024, Aurobindo Pharma USA Inc. recalled the Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Discoloration: Dotted and yellow spots on tablets
What you should do
- 1 Stop using Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Aurobindo Pharma USA Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Aurobindo Pharma USA Inc.
- Category
- Health
- Recall date
- May 15, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0492-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Aurobindo Pharma USA Inc. has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.